Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Oct 1, 2026
Reporting period
Not applicable
Filed with the SEC
Oct 3, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001022079-26-000090
Filed / recorded
Oct 3, 2026, 12:33 AM UTC
Added to OQRO
Oct 3, 2026, 11:40 AM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
QUEST DIAGNOSTICS INC
Issuer CIK
1022079
Ticker
DGX
Reporting person
Timothy C Wentworth
Relationship
Director
Security
Phantom Stock Units
Table
Derivative (Table II)
Transaction date
Oct 1, 2026
Transaction code
A
Shares / units
135
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
477
Ownership form
Direct
Amendment
No
Footnotes from the filing
Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.